AI-enabled HEOR & market access

Market access & HEOR.Deliverable in weeks not years.

Turn existing evidence into local dossiers and payer narratives.
Less manual drafting. Sources attached. Experts in control.

Explore a pilot See the workflow

Platform in development·Scoped service pilots

Evidence workspace/

Start with your evidence

Global value dossier

YOUR EXISTING NARRATIVE

Clinical evidence

STUDIES & PUBLICATIONS

Economic model outputs

INPUTS & ASSUMPTIONS

Existing work. A new starting point.

Local value dossier

DRAFT FOR REVIEW

Comparative clinical evidence

The pivotal trial compared the therapy with placebo plus standard care.

Economic assumptions

The base case uses a lifetime horizon and a healthcare payer perspective.

Confirm the local comparator and cost inputs.

Click a citation to inspect its sourceEXPERT SIGN-OFF REQUIRED

Illustrative workflow · Synthetic content, not a live AI run.

Designed forHEORHTAGlobal pricingMarket access

01 / TIME

Draft faster. Reuse more.

Turn existing evidence into local dossiers and payer narratives. Move from source material to review-ready drafts.

02 / CONFIDENCE

Build a more rigorous value story.

Connect clinical claims and economic assumptions to their sources. Give reviewers a clear path from conclusion to evidence.

03 / CONTROL

Reduce review effort. Retain control.

Surface local requirements, evidence gaps, and changed assumptions. Focus expert judgment where it determines the outcome.

Early access / Scoped pilots

Bring one deliverable.See what changes.

We’re developing Odyssey for HEOR and market-access teams. Start with one workflow. Compare time spent, review effort, and source coverage against your current process.

Time to first draftReview effortSource coverage